we are passionate in our commitment to save and improve the lives of patients.

We are a late-stage company developing fusion protein medicines. Our fusion protein approach tethers a tumor-targeting antibody fragment to a protein cytotoxic payload to form a single protein molecule designed to selectively and broadly kill cancer cells while minimizing toxicity to healthy cells and to activate the body’s innate immune response system.

executive leadership team

Thomas Cannell, DVM

President, CEO & Director

Erin Clark

Vice President, Corporate Strategy and Investor Relations

Monica Forbes

Chief Financial Officer

Glen MacDonald, Ph.D.

Chief Technology Officer

Chad A. Myskiw, Ph.D.

Vice President of Supply Chain and Manufacturing Strategy

Omar Rifi

Vice President, Business Development and Alliance Management

Minori Rosales, M.D., Ph.D.,

Chief Development Officer

Mark R. Sullivan

General Counsel, Chief Compliance Officer & Corporate Secretary

board of directors

Thomas Cannell, DVM

President, CEO & Director

Jay S. Duker, MD

Chair of the Board of Directors

Carrie L. Bourdow


Peter K Honig, MD, MPH


Michael A.S. Jewett, MD, FRCSC, FACS


Jason Keyes


ceo medical advisory board

Rian Dickstein, MD, FACS

Chief of Urology - University of Maryland Baltimore Washington Medical Center

Wassim Kassouf, MD, CM, FRCSC

Professor and Associate Chair Dept. of Surgery - McGill University

Thomas Keane, MD

Medical University of South Carolina (Charleston) – Professor and Chair Department of Urology

Donald Lamm, MD

Clinical Professor, University of Arizona

Michael O’Donnell, MD

Richard D Williams Professor and Director of Urologic Oncology University of Iowa Carver College of Medicine

Neal D. Shore, MD, FACS

Director, CPI, Carolina Urologic Research Center Atlantic Urology Clinics Myrtle Beach, South Carolina

Alon Weizer, MD

Professor of Urology – University of Michigan

Fred N. Wolk, MD, FACS

Director of Clinical Trials, Skyline Urology Torrance, CA

ceo advisors

Wendy L. Dixon, Ph.D.

CEO Advisor

Dana Dunn, MS

CEO Advisor

Jane V. Henderson

CEO Advisor

Howard L. Levine, Ph.D.

CEO Advisor

Daniel S. Lynch, MBA

CEO Advisor

Louise Park Stejbach

CEO Advisor